Scholarlink

Background &amp; objectives <p>Migraine is more prevalent among healthcare providers (HCPs), which adversely affects the quality of life and work productivity. This study aimed to screen for migraine in HCPs working at Kasr Al-Ainy Hospital and its drawbacks on work productivity.</p> Methods <p>This door-to-door survey was held at the workplace, targeting HCPs at Kasr Al-Ainy Hospital. Migraine screening was conducted based on the migraine diagnostic criteria of the International Classification of Headache Disorders— 3rd edition. Healthcare providers with migraines were requested to answer the Migraine Disability Assessment Test (MIDAS) and the Work Productivity and Activity Impairment Questionnaire—General Health Version (WPAI-GH). Absenteeism, presenteeism, and economic loss due to migraine were calculated.</p> <b>Results</b> <p>One thousand one hundred seventy-nine HCPs working at Kasr Al-Ainy Hospital agreed to participate in our survey. Only 387 (32.8%) participants met the diagnostic criteria of migraine, 31.8% of them had MIDAS grade-IV. The mean score of the WPAI-GH was 60.47 ± 40. The mean percent of absenteeism and presenteeism was 12.29% and 46%, respectively. The mean economic loss caused by absenteeism and presenteeism was $29.4 and $38.2, respectively. Participants with MIDAS grade-IV had significantly higher absenteeism, presenteeism, and economic loss than those in lower grades. Although 159 HCPs with migraine had indications for prophylactic treatment, only 73.6% received it.</p> Conclusion <p>About one-third of HCPs at Kasr Al-Ainy Hospital suffered from migraines, which negatively affected their work productivity, with higher presenteeism than absenteeism. Strenuous efforts should be directed toward reducing the cost burden associated with migraine.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impact of migraine on work productivity of healthcare providers at Kasr Al-Ainy Hospital

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月29日

查看全文
  • Wesam Osama,
  • Rehab Magdy,
  • Salsabil Abo Al-Azayem,
  • Eman Hany Elsebaie,
  • Aya Abou Amer,
  • Abdelhameed Mahros Abdelhameed Elshenawey,
  • Fatma Hossni Abdellatif Abdelghany,
  • Radwa Mohammed Elsayed,
  • Dina Farouk,
  • Shehab M. Moawad,
  • Shehab Samir,
  • Ahmed R. N. Ibrahim,
  • Khalid M. Orayj,
  • Lamiaa N. Abdelaty,
  • Nesma Mounir

摘要

Background & objectives

Migraine is more prevalent among healthcare providers (HCPs), which adversely affects the quality of life and work productivity. This study aimed to screen for migraine in HCPs working at Kasr Al-Ainy Hospital and its drawbacks on work productivity.

Methods

This door-to-door survey was held at the workplace, targeting HCPs at Kasr Al-Ainy Hospital. Migraine screening was conducted based on the migraine diagnostic criteria of the International Classification of Headache Disorders— 3rd edition. Healthcare providers with migraines were requested to answer the Migraine Disability Assessment Test (MIDAS) and the Work Productivity and Activity Impairment Questionnaire—General Health Version (WPAI-GH). Absenteeism, presenteeism, and economic loss due to migraine were calculated.

Results

One thousand one hundred seventy-nine HCPs working at Kasr Al-Ainy Hospital agreed to participate in our survey. Only 387 (32.8%) participants met the diagnostic criteria of migraine, 31.8% of them had MIDAS grade-IV. The mean score of the WPAI-GH was 60.47 ± 40. The mean percent of absenteeism and presenteeism was 12.29% and 46%, respectively. The mean economic loss caused by absenteeism and presenteeism was $29.4 and $38.2, respectively. Participants with MIDAS grade-IV had significantly higher absenteeism, presenteeism, and economic loss than those in lower grades. Although 159 HCPs with migraine had indications for prophylactic treatment, only 73.6% received it.

Conclusion

About one-third of HCPs at Kasr Al-Ainy Hospital suffered from migraines, which negatively affected their work productivity, with higher presenteeism than absenteeism. Strenuous efforts should be directed toward reducing the cost burden associated with migraine.